Shimadzu’s new ultra-high performance liquid chromatography system is designed to solve common problems in Biopharma Analysis. Shimadzu launched its new Nexera XS inert, a bioinert and biocompatible ultra-high performance liquid chromatograph (UHPLC), in July 2022. The system is designed to resolve the most common problems in biopharmaceutical analysis, such as the adsorption of target molecules […]

The post Shimadzu’s Nexera XS Inert Chromatography System Enhances Biopharma Analysis first appeared on World Pharma Today.